ABT vs QVCC · P/E 25, rev $44.33B vs rev $9.00B
Abbott Laboratories (ABT) versus QVCC (QVCC) — a side-by-side from cached financials, not a winner call.
Abbott Laboratories (ABT) is a medical devices company listed on NYSE.
QVCC (QVCC) is a other company listed on NYSE.
Latest reported ABT revenue for 2025-12-31 was $44.33B. Net income was $6.52B. Revenue was up 5.7% from 2024-12-31 to 2025-12-31. ABT currently screens at market cap $154.15B and trailing P/E 24.8.
Latest reported QVCC revenue for 2024-12-31 was $9.00B. Net income was -$1.02B. Revenue was down 4.8% from 2023-12-31 to 2024-12-31.
ABT currently screens at market cap $154.15B and trailing P/E 24.8.
Not investment advice. Open the ABT and QVCC stock pages for the full models.
Not investment advice.